Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Monte Rosa Therapeutics, Inc. | Chief Medical Officer | Common Stock | 5.25K | $99.8K | $19.00 | Jan 2, 2024 | Direct |
Monte Rosa Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 30K | Sep 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
GLUE | Monte Rosa Therapeutics, Inc. | Sep 13, 2024 | 1 | $0 | 4 | Sep 13, 2024 | Chief Medical Officer |
GLUE | Monte Rosa Therapeutics, Inc. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Chief Medical Officer |
GLUE | Monte Rosa Therapeutics, Inc. | Jan 3, 2023 | 1 | $0 | 4 | Jan 4, 2023 | Chief Medical Officer |
GLUE | Monte Rosa Therapeutics, Inc. | Dec 15, 2022 | 1 | $0 | 4 | Dec 19, 2022 | Chief Medical Officer |
GLUE | Monte Rosa Therapeutics, Inc. | Oct 31, 2022 | 1 | $0 | 4 | Nov 1, 2022 | Chief Medical Officer |
GLUE | Monte Rosa Therapeutics, Inc. | Mar 1, 2022 | 1 | $0 | 4 | Mar 2, 2022 | Chief Medical Officer |
GLUE | Monte Rosa Therapeutics, Inc. | Jun 23, 2021 | 1 | $0 | 4 | Jun 25, 2021 | Chief Medical Officer |
GLUE | Monte Rosa Therapeutics, Inc. | Jun 23, 2021 | 0 | $0 | 3 | Jun 23, 2021 | Chief Medical Officer |